HMG-CoA reductase inhibitors reduce vascular monocyte chemotactic protein-1 expression in early lesions from hypercholesterolemic swine independently of their effect on plasma cholesterol levels (original) (raw)

Vascular effects of HMG CoA-reductase inhibitors (statins) unrelated to cholesterol lowering: new concepts for cardiovascular disease

David Lefer

Cardiovascular Research, 2001

View PDFchevron_right

HMG-CoA reductase inhibition by atorvastatin reduces neointimal inflammation in a rabbit model of atherosclerosis

Fernando Perez

Journal of The American College of Cardiology, 1998

View PDFchevron_right

Statin Therapy Alone and in Combination with an Acyl-CoA:Cholesterol O-Acyltransferase Inhibitor on Experimental Atherosclerosis

Roberto Corti

Pathophysiology of Haemostasis and Thrombosis, 2007

View PDFchevron_right

The evolving role of statins in the management of atherosclerosis

carl vaughan

Journal of the American College of Cardiology, 2000

View PDFchevron_right

Effects of statins on matrix metalloproteinases and their endogenous inhibitors in human endothelial cells

Luane Gonçalves

Naunyn-schmiedebergs Archives of Pharmacology, 2011

View PDFchevron_right

Oxidised Low Density Lipoprotein (LDL) Modification with Statin Therapy is Associated with Reduction in Carotid Stenosis

E. Skopelitis

Carotid Artery Disease - From Bench to Bedside and Beyond, 2014

View PDFchevron_right

The effects of statins on endothelium, inflammation and cardioprotection

David Lefer

Drug News & Perspectives, 2005

View PDFchevron_right

Comparative effects of statin and fibrate on nitric oxide bioactivity and matrix metalloproteinase in hyperlipidemia

tae yong ahn

International Journal of Cardiology, 2004

View PDFchevron_right

Rosuvastatin reduces MMP-7 secretion by human monocyte-derived macrophages: potential relevance to atherosclerotic plaque stability

Jean-Charles Fruchart

Atherosclerosis, 2004

View PDFchevron_right

Anti-atherogenic effects of statins: Impact on angiopoietin-2 release from endothelial cells

Andreas Hoeft, Sven Klaschik, Stilla Frede

Biochemical Pharmacology, 2013

View PDFchevron_right

Association between reduced low density lipoprotein oxidation and inhibition of monocyte chemoattractant protein-1 production in statin-treated subjects

Robert Rosenson

Journal of Laboratory and Clinical Medicine, 2005

View PDFchevron_right

Nitric oxide synthase II (NOS II) gene expression correlates with atherosclerotic intimal thickening. Preventive effects of HMG-CoA reductase inhibitors

Jose Alfon

Atherosclerosis, 1999

View PDFchevron_right

Potency of select statin drugs in a new mouse model of hyperlipidemia and atherosclerosis

Thomas Johnston

International Journal of Pharmaceutics, 2001

View PDFchevron_right

Rapid, Direct Effects of Statin Treatment on Arterial Redox State and Nitric Oxide Bioavailability in Human Atherosclerosis via Tetrahydrobiopterin-Mediated Endothelial Nitric Oxide Synthase Coupling

Michael Demosthenous

Circulation, 2011

View PDFchevron_right

HMG-COA Reductase Inhibition by Simvastatin Reduces Neointimal Inflammation in a Rat Model of Atherosclerosis

Prof. Md. Sayedur Rahman

Bangladesh Journal of Physiology and Pharmacology, 2014

View PDFchevron_right

Basic science review: Statin therapy--Part I: The pleiotropic effects of statins in cardiovascular disease

Benjamin Sadowitz

Vascular and endovascular surgery, 2010

View PDFchevron_right

The Role of Statins in Vascular Disease

Peter Laws, J. Spark

European Journal of Vascular and Endovascular Surgery, 2004

View PDFchevron_right

Anti-atherogenic effect of statins: role of nitric oxide, peroxynitrite and haem oxygenase-1

T. Malinski

British Journal of Pharmacology, 2009

View PDFchevron_right

Impact of Statins in Ischemic Heart Disease

Karunakaran Gauthaman

2011

View PDFchevron_right

Endothelial Dysfunction, Oxidative Stress and Inflammation: Implications in Atherogenesis, Cardiovascular Diseases and Gene Targeted Therapeutic Approach

Olamide O Crown

Journal of Pharmacology and Toxicology, 2023

View PDFchevron_right

Fluvastatin Reduces Tissue Factor Expression and Macrophage Accumulation in Carotid Lesions of Cholesterol-Fed Rabbits in the Absence of Lipid Lowering

Michael Ezekowitz

Arteriosclerosis, Thrombosis, and Vascular Biology, 2002

View PDFchevron_right

Statins Alter Smooth Muscle Cell Accumulation and Collagen Content in Established Atheroma of Watanabe Heritable Hyperlipidemic Rabbits

Elena Aikawa

Circulation, 2001

View PDFchevron_right

The lipid and non-lipid effects of statins

Robin Poston

Pharmacology & Therapeutics, 2003

View PDFchevron_right

Effects of local MCP-1 protein therapy on the development of the collateral circulation and atherosclerosis in Watanabe hyperlipidemic rabbits

Sawa Kostin, Wolfgang Schaper

Cardiovascular Research, 2003

View PDFchevron_right

HMG-CoA Reductase Inhibitors Regulate Inflammatory Transcription Factors in Human Endothelial and Vascular Smooth Muscle Cells

Otmar Pachinger, Matthias Frick

Arteriosclerosis, Thrombosis, and Vascular Biology, 2003

View PDFchevron_right

Intensive Treatment With Atorvastatin Reduces Inflammation in Mononuclear Cells and Human Atherosclerotic Lesions in One Month

Almudena Gómez-hernández, José Tuñón

Stroke, 2005

View PDFchevron_right